Emory-CDC HIV prevention and treatment clinical unit
Emory-CDC CTU
This Emory-CDC clinical unit runs HIV vaccine, prevention, and treatment studies for adults, women, adolescents, and people in the U.S. and partner countries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11410961 on NIH RePORTER |
What this research studies
If I join this unit I would be taking part in NIH‑network clinical studies run by Emory and CDC sites that test new HIV prevention methods, vaccines, and treatment approaches including cure and management of related infections and comorbidities. The unit is made up of multiple clinical research sites and is expanding to include a site in Mexico City to support both domestic and low‑ and middle‑income country work. The team prioritizes enrolling women, minorities, and adolescents and can open studies quickly in response to emerging research opportunities. Participation could involve visits for screening, treatment or prevention interventions, and follow‑up monitoring per each study's plan.
Who could benefit from this research
Good fit: Ideal candidates include adults living with HIV, pregnant or postpartum women, adolescents, and people at high risk for HIV who meet a specific study's eligibility criteria at participating sites.
Not a fit: People who live far from participating sites, are outside the eligible age or health criteria for a given study, or who cannot attend required visits may not receive direct benefit.
Why it matters
Potential benefit: If successful, this work could bring new prevention options, better treatments, and more inclusive access to HIV studies for women, minorities, and adolescents.
How similar studies have performed: Past clinical trials have produced effective antiretroviral therapies and prevention tools like PrEP, while HIV vaccines and cure strategies have had mixed results, so this unit builds on both established successes and ongoing research challenges.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kelley, Colleen F — Emory University
- Study coordinator: Kelley, Colleen F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.